WVP
ANVS icon

Worth Venture Partners’s Annovis Bio ANVS Stock Holding History

Worth Venture Partners’s Portfolio ANVS Stock Details ANVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,321
Closed -$117K – 134
2023
Q3 		$117K Sell
12,321
-92,330
-88% -$1.14M 0.07% 116
2023
Q2 		$1.5M Buy
+104,651
New +$1.48M 0.81% 38
2021
Q4 		– Sell
-19,878
Closed -$631K – 135
2021
Q3 		$631K Sell
19,878
-13,956
-41% -$802K 0.28% 82
2021
Q2 		$2.9M Buy
33,834
+3,866
+13% +$179K 1.08% 34
2021
Q1 		$836K Sell
29,968
-89,570
-75% -$1.92M 0.41% 61
2020
Q4 		$901K Hold
119,538
– – 0.71% 40
2020
Q3 		$575K Sell
119,538
-20,079
-14% -$107K 0.47% 52
2020
Q2 		$607K Sell
139,617
-4,133
-3% -$17.1K 0.3% 53
2020
Q1 		$432K Buy
+143,750
New +$708K 0.27% 56

Other funds holding ANVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WFAG
Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.14B AUM 16.59% 1-Year Est. Return
SIAP
Sterling Investment Advisors (Pennsylvania) Berwyn, Pennsylvania $599M AUM 28.66% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Worth Venture Partners's ANVS Position: Q4 2023 in Review

Worth Venture Partners sold out of Annovis Bio (ANVS) in Q4 2023, closing a stake of 12,321 shares — an estimated $117K sold.

Worth Venture Partners first reported a position in ANVS in Q1 2020 and held it in 9 quarters. The position peaked at $2.9M in Q2 2021. 36 funds tracked by Wall St. Rank hold ANVS as of Q4 2023.

  • Worth Venture Partners reported no remaining Annovis Bio position as of Q4 2023 after selling out during the quarter.
  • Worth Venture Partners sold 12,321 Annovis Bio shares in Q4 2023, an estimated $117K.
  • Worth Venture Partners first reported a position in Annovis Bio in Q1 2020 and held it in 9 quarters.
  • Worth Venture Partners's Annovis Bio position peaked at $2.9M in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2023.

Based on Worth Venture Partners's 13F filing for Q4 2023, filed 9 Feb 2024.